ABMT (Advanced BioMedical Technologies) Research & Development: $0.22 Mil (TTM As of Jul. 2021)


What is Advanced BioMedical Technologies Research & Development?

Advanced BioMedical Technologies ABMT Research & Development is $0.22 Mil as of Jul. 2021.

Research & Development is the aggregate amount of research and development expenses during the year. Advanced BioMedical Technologies's Research & Development for the three months ended in Jul. 2021 was $0.06 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jul. 2021 was $0.22 Mil.

Advanced BioMedical Technologies  (OTCPK:ABMT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Advanced BioMedical Technologies Research & Development Related Terms

Advanced BioMedical Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Research & Development Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.05 0.06 0.26 0.18

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.07 0.06 0.06

Advanced BioMedical Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jul. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.22 Mil mean?
Advanced BioMedical Technologies (ABMT) has a Research & Development of $0.22 Mil as of Jul. 2021. Research and development expense is the total cost for research and development activities. View historical data on Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' Research & Development too high?
Advanced BioMedical Technologies' current Research & Development is $0.22 Mil.
How does Advanced BioMedical Technologies' Research & Development compare to VYCO and ADMT?
Advanced BioMedical Technologies' Research & Development of $0.22 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current Research & Development is $0.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current Research & Development of $0.22 Mil. The current Research & Development is $0.22 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current Research & Development is $0.22 Mil as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.